Biotech · Private company
NaviFUS Corporation
Track this companyFree. Adds NaviFUS Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials65 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- BevacizumabPhase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- LumasonPhase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- NaviFUS SystemPhase 2 · Drug Resistant EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- NaviFUS SystemPhase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Low-Intensity Focused Ultrasound for Gambling DisorderNA · NOT_YET_RECRUITING · started Feb 1, 2027ClinicalTrials.gov NCT07923032 · fetched Nov 12, 2026
- Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent GlioblastomaNA · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07274787 · fetched Nov 12, 2026
- Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair DeficiencyPHASE1 · NOT_YET_RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT07385846 · fetched Nov 12, 2026
- Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated GlioblastomaPHASE1 · RECRUITING · started Mar 23, 2026ClinicalTrials.gov NCT07343986 · fetched Nov 12, 2026
- Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)PHASE1_PHASE2 · SUSPENDED · started Oct 22, 2024ClinicalTrials.gov NCT06329570 · fetched Nov 12, 2026
- A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant EpilepsyPHASE1_PHASE2 · RECRUITING · started Sep 13, 2024ClinicalTrials.gov NCT06388707 · fetched Nov 12, 2026